Cell & gene therapies
Cell therapies use cells as part of treatment. Gene therapies introduce or modify genetic material. Some approaches combine both, including CAR-T cell therapy.
Exploring cell and gene therapy can bring new questions. CGT Healthcare helps you understand potential pathways and coordinates the clinical, scientific, and partner review needed to assess what may be possible.

Cell therapies use cells as part of treatment. Gene therapies introduce or modify genetic material. Some approaches combine both, including CAR-T cell therapy.
Our team helps coordinate the work involved in evaluating potential pathways—from medical review and cell collection to engagement with clinical, scientific, and industry partners.
The appropriate next step depends on your condition, available options, therapy requirements, and relevant approvals. An evaluation does not guarantee access to treatment.
Every patient’s needs are different. Your care team helps explain the process and the decisions involved.

Share your questions and learn what information is needed to begin a medical review.
Your medical needs, available therapies, eligibility, and clinical feasibility guide the evaluation.
Depending on your pathway, coordination may include cell collection, relevant partners, and access requirements.
Understand the proposed services and requirements. Each step requires separate authorization before work begins.
Cell collection is not the therapy itself. The suitability and use of collected cells require review by the treating team and relevant manufacturing or treatment partners.

Explore the science, the collection experience, and how a potential care pathway is evaluated.
Read online or save the PDF to explore at your own pace.
Whether you’re exploring a potential therapy pathway or considering cell banking, our team is here to help.